代替がん治療市場 - 世界の産業規模、シェア、動向、機会、予測：治療タイプ別、疾患タイプ別、エンドユーザー別、地域別、競合別、2020年～2030年

代替がん治療の世界市場規模は2024年に156億5,000万米ドル、予測期間中のCAGRは9.62%で2030年には269億4,000万米ドルに達すると予測されています。

世界の代替がん治療市場は、化学療法や放射線療法などの従来型治療と並行して、あるいはその代わりに、非従来型治療を求める患者の増加に伴い急速に拡大しています。この市場には、漢方薬、免疫に基づく治療、サイトカイン療法やモノクローナル抗体などの生物学的製剤など、身体の自然な防御力を高めることを目的とした幅広い治療が含まれます。この市場の成長を支える重要な要因のひとつは、従来のがん治療がもたらす潜在的な副作用に対する患者やヘルスケア提供者の意識が高まっていることです。その結果、患者のQOLの改善、副作用の軽減、治療成績の向上が期待できる補完代替療法に対する需要が高まっています。特に免疫療法は、がん細胞を標的としてより選択的に攻撃し、健康な組織への害が少ないことから、大きな支持を得ています。2024年6月、米国食品医薬品局（FDA）はepcoritamab-bysp（エプキンリー、Genmab U.S.社）を2ライン以上の全身療法後の再発または難治性の濾胞性リンパ腫（FL）の成人患者を対象に承認しました。

市場促進要因

がん罹患率の上昇

主な市場課題

標準化された規制の欠如

主要市場動向

従来療法と代替療法の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の代替がん治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 治療タイプ別（ホルモン療法、鍼治療、栄養補助食品、その他）
  • 疾患タイプ別（消化器がん、肺がん、乳がん、大腸がん、白血病、リンパ腫、黒色腫、前立腺がん、その他）
  • エンドユーザー別（病院・クリニック、がん・放射線治療センター、在宅ケア、その他）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • 治療タイプ別
  • 疾患タイプ別
  • エンドユーザー別
  • 地域別

第6章 北米の代替がん治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の代替がん治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の代替がん治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の代替がん治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの代替がん治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• がんの罹患率の増加
• ヘルスケア費の増加
• 課題
• 新しい治療法に関する認識の欠如
• 高額な治療費

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の代替がん治療市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Innovative Medicine, LLC
• Northwest Natural Health Clinic
• Immunotherapy Institute
• Georgia Cancer Specialists
• Holistic Bio Spa
• Johnson & Johnson
• Celgene Corporation
• Astellas Pharma, Inc.
• Novartis AG
• Merck KGaA

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Alternative Cancer Therapeutics Market was valued at USD 15.65 billion in 2024 and is expected to reach USD 26.94 billion by 2030 with a CAGR of 9.62% during the forecast period. The global alternative cancer therapeutics market is rapidly expanding as more patients seek non-traditional treatments alongside or in place of conventional therapies like chemotherapy and radiation. This market encompasses a wide range of therapies, including herbal medicines, immune-based treatments, and biologics, such as cytokine therapies and monoclonal antibodies, which aim to enhance the body's natural defenses. One significant driver behind the growth of this market is the increasing awareness among patients and healthcare providers about the potential side effects of conventional cancer treatments. As a result, there is a rising demand for complementary and alternative therapies that promise to improve patient quality of life, reduce side effects, and enhance treatment outcomes. Immunotherapies, in particular, have gained significant traction due to their ability to target and attack cancer cells more selectively, causing less harm to healthy tissues. In June 2024, the U.S. Food and Drug Administration (FDA) approved epcoritamab-bysp (Epkinly, Genmab U.S., Inc.) for adult patients with relapsed or refractory follicular lymphoma (FL) following two or more lines of systemic therapy.

Key Market Drivers

Rising Cancer Incidence

The rising global incidence of cancer is a significant driver of the alternative cancer therapeutics market. For instance, according to the WHO 2025 report, cancer is a leading global cause of death, responsible for nearly 10 million deaths in 2020, or one in six deaths. Common cancers include breast, lung, colon, rectum, and prostate. One-third of cancer deaths are linked to tobacco, obesity, alcohol, poor diet, physical inactivity, and air pollution. As the number of cancer diagnoses continues to increase worldwide, there is a growing demand for diverse treatment options, including alternative therapies. The global cancer burden is influenced by various factors, such as aging populations, lifestyle changes, and environmental exposures. With the traditional cancer treatment methods like chemotherapy and radiation often resulting in harsh side effects, patients are increasingly seeking complementary or alternative approaches to manage their condition and improve their overall well-being. According to the WHO, cancer affects 1 in 5 people, with 1 in 12 women and 1 in 9 men impacted. In 2022, there were 20 million new cancer cases and 9.7 million deaths, while 53.5 million people were alive five years after diagnosis.

As conventional treatments may lead to fatigue, nausea, hair loss, and weakened immune function, cancer patients are looking for therapies that are less invasive, have fewer side effects, and support their overall health. This shift has sparked an increased interest in alternative treatments such as herbal remedies, immunotherapies, and biological treatments, which are believed to offer more targeted and holistic healing solutions. The failure of traditional therapies to cure certain cancer types or the recurrence of the disease after conventional treatment drives patients to explore alternative options that may offer more favorable outcomes.

The rising cancer incidence has also led to greater awareness and acceptance of alternative cancer treatments. Many patients, particularly in developed regions, are more open to exploring non-traditional therapies after experiencing the limitations and side effects of standard treatments. Alongside this, the growing body of research supporting the effectiveness of certain alternative cancer therapies, such as cannabis-based treatments, naturopathy, and immunotherapy, continues to bolster the credibility and demand for these options. As the global cancer epidemic worsens, the alternative cancer therapeutics market is expected to grow, driven by patient demand for more personalized and less toxic treatment regimens to combat cancer.

The growing prevalence of lifestyle disorders like diabetes and obesity, increasing healthcare spending, and the rapidly expanding diagnostic industry are fueling market growth. For example, the American Diabetes Association reports 1.2 million new diabetes diagnoses annually, with 11.6% of Americans affected in 2021. Additionally, the aging population, rising demand for laboratory automation, and greater awareness of preventive healthcare are contributing to market expansion.

Key Market Challenges

Lack of Standardized Regulations

The lack of standardized regulations in the global alternative cancer therapeutics market presents a significant challenge, hindering the widespread acceptance and integration of these treatments into mainstream oncology care. Unlike conventional cancer therapies, which are subject to rigorous regulatory frameworks such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), many alternative treatments-such as herbal remedies, supplements, and other non-traditional therapies-are not consistently regulated. This lack of standardization results in variations in product quality, safety, and efficacy, which can lead to confusion and mistrust among patients and healthcare providers.

Without a universal regulatory framework, the market is flooded with alternative treatments of varying potency, purity, and effectiveness. This inconsistency not only creates challenges for patients seeking reliable treatments but also for healthcare professionals who may find it difficult to recommend or integrate these therapies into their treatment plans. The absence of standardized manufacturing processes means that some alternative cancer treatments may contain harmful substances or contaminants, further raising concerns over patient safety.

The lack of regulation also impacts the clinical development of alternative cancer therapies. Without clear guidelines or standards, it becomes challenging for researchers and companies to conduct large-scale clinical trials to validate the effectiveness of these treatments. As a result, many alternative therapies lack the robust scientific evidence needed to prove their therapeutic value, leaving them on the fringes of cancer care. The patients may turn to unregulated alternative therapies when they seek relief from the side effects of conventional treatments. However, the risk of ineffective or potentially harmful treatments without regulatory oversight increases. A unified regulatory approach, focused on ensuring the safety, efficacy, and quality of alternative cancer therapies, would provide greater confidence to both patients and healthcare providers, promoting the responsible integration of these therapies into cancer treatment protocols.

Key Market Trends

Integration of Conventional and Alternative Therapies

The integration of conventional and alternative therapies is one of the most notable trends in the global alternative cancer therapeutics market, reflecting a shift towards more holistic, personalized, and patient-centered approaches to cancer care. Conventional cancer treatments such as chemotherapy, radiation, and surgery remain the primary modalities for cancer management. However, these treatments often come with significant side effects, such as fatigue, nausea, hair loss, and immune suppression, which can greatly affect a patient's quality of life. As a result, there has been growing interest in integrating alternative therapies, such as acupuncture, herbal remedies, and dietary supplements, into conventional treatment plans to mitigate these side effects and improve overall patient well-being.

Integrative oncology, which combines the best of both conventional and alternative therapies, is gaining acceptance among healthcare providers and patients alike. This approach not only focuses on targeting the cancer itself but also emphasizes addressing the physical, emotional, and psychological needs of cancer patients. By incorporating therapies like yoga, mindfulness meditation, and naturopathy, integrative oncology aims to improve the overall health of the patient and enhance the body's ability to cope with the side effects of aggressive cancer treatments.

Moreover, the growing body of research supporting the benefits of complementary therapies is further promoting this trend. Clinical studies have shown that treatments like acupuncture can reduce pain and nausea associated with chemotherapy, while certain herbal supplements may help enhance the effectiveness of conventional drugs. As a result, cancer care centers and hospitals are increasingly adopting integrative care models, and multidisciplinary teams are collaborating to provide comprehensive treatment plans that combine the latest advancements in both conventional and alternative medicine. This integration not only supports the growing demand for alternative cancer therapies but also opens new avenues for improving patient outcomes and quality of life.

Key Market Players

• Innovative Medicine, LLC
• Northwest Natural Health Clinic
• Immunotherapy Institute
• Georgia Cancer Specialists
• Holistic Bio Spa
• Johnson & Johnson
• Celgene Corporation
• Astellas Pharma, Inc.
• Novartis AG
• Merck KGaA

Report Scope:

In this report, the Global Alternative Cancer Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Alternative Cancer Therapeutics Market, By Therapy Type:

• Hormone Therapies
• Acupuncture and Dietary Supplements
• Others

Alternative Cancer Therapeutics Market, By Disease Type:

• Gastrointestinal
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Leukemia
• Lymphoma
• Melanoma
• Prostate Cancer
• Others

Alternative Cancer Therapeutics Market, By End Users:

• Hospitals and Clinics
• Cancer and Radiation Therapy Center
• Home Care
• Others

Alternative Cancer Therapeutics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Alternative Cancer Therapeutics Market.

Available Customizations:

Global Alternative Cancer Therapeutics Market report with the given market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Alternative Cancer Therapeutics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 5.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 5.2.3. By End Users (Hospitals and Clinics, Cancer and Radiation Therapy Center, Home Care, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Therapy Type
  • 5.3.2. By Disease Type
  • 5.3.3. By End Users
  • 5.3.4. By Region

6. North America Alternative Cancer Therapeutics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 6.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 6.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Alternative Cancer Therapeutics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Therapy Type
      • 6.3.1.2.2. By Disease Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Alternative Cancer Therapeutics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Therapy Type
      • 6.3.2.2.2. By Disease Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Alternative Cancer Therapeutics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Therapy Type
      • 6.3.3.2.2. By Disease Type
      • 6.3.3.2.3. By End User

7. Europe Alternative Cancer Therapeutics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 7.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 7.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Alternative Cancer Therapeutics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapy Type
      • 7.3.1.2.2. By Disease Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Alternative Cancer Therapeutics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapy Type
      • 7.3.2.2.2. By Disease Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Alternative Cancer Therapeutics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapy Type
      • 7.3.3.2.2. By Disease Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Alternative Cancer Therapeutics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Therapy Type
      • 7.3.4.2.2. By Disease Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Alternative Cancer Therapeutics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Therapy Type
      • 7.3.5.2.2. By Disease Type
      • 7.3.5.2.3. By End User

8. Asia-Pacific Alternative Cancer Therapeutics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 8.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 8.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Alternative Cancer Therapeutics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapy Type
      • 8.3.1.2.2. By Disease Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Alternative Cancer Therapeutics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapy Type
      • 8.3.2.2.2. By Disease Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Alternative Cancer Therapeutics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapy Type
      • 8.3.3.2.2. By Disease Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Alternative Cancer Therapeutics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapy Type
      • 8.3.4.2.2. By Disease Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Alternative Cancer Therapeutics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapy Type
      • 8.3.5.2.2. By Disease Type
      • 8.3.5.2.3. By End User

9. South America Alternative Cancer Therapeutics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 9.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 9.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Alternative Cancer Therapeutics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapy Type
      • 9.3.1.2.2. By Disease Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Alternative Cancer Therapeutics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapy Type
      • 9.3.2.2.2. By Disease Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Alternative Cancer Therapeutics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapy Type
      • 9.3.3.2.2. By Disease Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Alternative Cancer Therapeutics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others)
  • 10.2.2. By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others)
  • 10.2.3. By End Users (Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Alternative Cancer Therapeutics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapy Type
      • 10.3.1.2.2. By Disease Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Alternative Cancer Therapeutics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapy Type
      • 10.3.2.2.2. By Disease Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Alternative Cancer Therapeutics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapy Type
      • 10.3.3.2.2. By Disease Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.1.1 Growing Prevalence of Cancer
• 11.1.2 Growing Healthcare Expenditure
• 11.2. Challenges
• 11.2.1 Lack of Awareness about New Therapies
• 11.2.2 High Cost of Treatment

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Alternative Cancer Therapeutics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Innovative Medicine, LLC
  • 15.1.1. Business Overview
  • 15.1.2. Product Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Northwest Natural Health Clinic
• 15.3. Immunotherapy Institute
• 15.4. Georgia Cancer Specialists
• 15.5. Holistic Bio Spa
• 15.6. Johnson & Johnson
• 15.7. Celgene Corporation
• 15.8. Astellas Pharma, Inc.
• 15.9. Novartis AG
• 15.10. Merck KGaA

16. Strategic Recommendations

17. About Us & Disclaimer